Recombinant factor VIII concentrates are stable when administered in a reco
nstituted form according to the manufacturer's specifications, and undilute
d via infusion with syringe mini-pumps. However many Haemophilia centres ad
minister recombinant factor VIII further diluted in intravenous fluids for
greater ease of administration. To investigate the stability of recombinant
factor VIII during administration as a diluted infusion, reconstituted fac
tor VIII was stored in polyvinylchloride (PVC) mini-bags undiluted (146 IU
mL(-1)) and at factor VIII concentrations of 10 IU mL(-1) and 2 IU mL(-1).
After 48 h of storage at room temperature in PVC mini-bags, the recoveries
of factor VIII activity were 41.9% of the initial activity for the undilute
d (146 IU mL(-1)) product and 43.7% of the initial activity for factor VIII
diluted to 10 IU mL(-1). For factor VIII diluted to 2 IU mL(-1), the amoun
t of factor VIII activity remaining at 48 h was only 1.8% of the initial ac
tivity. In contrast, 100% of factor VIII activity was recovered after 48 h
when undiluted reconstituted product (146 IU mL(-1)) was stored in a syring
e. To investigate the mechanism of factor VIII activity loss during storage
, factor VIII samples collected after 0, 3 and 48 h of storage were analyse
d by immunoblotting with factor VIII antibodies. No evidence of factor VIII
proteolytic degradation during storage was found, however, large amounts o
f factor VIII antigen were recovered from the empty PVC mini-bags following
elution with denaturing detergent. We conclude that clinically significant
losses of factor VIII activity occur during storage in PVC mini-bags and t
hat the loss of activity is most likely due to protein adsorption onto the
plastic surface. This loss of factor VIII activity during storage in PVC co
ntainers may substantially affect the safety and potential cost savings of
administering recombinant factor VIII by continuous infusion.